V201 Study

Lakeland Clinical Trials is conducting a clinical trial to evaluate the safety and efficacy of different formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults ≥50 Years of Age 

You may be eligible to participate if:

  • You are aged over 50
  • Have not received a flu vaccination in the last 6 months

This trial is no longer enrolling but if you would like to register your interest for future clinical trials please apply via the 'APPLY TO PARTICIPATE' button.

Project Data

SPONSOR

Seqirus

Apply to Participate